Psyence Biomedical Ltd. (PBM) appoints Albert Garcia-Romeu as Chair of new Scientific Advisory Board Mar 10, 2025 11:25AM
Psyence Biomedical (PBM) Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant Sep 6, 2024 07:30AM
Psyence Biomedical (PBM) Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin Sep 4, 2024 07:31AM